Study of antimicrobial consumption in Intensive Care Center of a University hospital in the North Region
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/27592 |
Resumo: | The indiscriminate and excessive use of antimicrobials directly contributes to the development of bacterial resistance, increasing treatment expenses, morbidity and mortality rates, hospitalization time, and various adverse reactions. Therefore, the study's objective was to evaluate and quantify the consumption of antimicrobials used in the ICU of a Federal Public Hospital. Antimicrobial consumption was expressed as a defined daily dose (DDD) per 1000 patients/day. It was used in the World Health Organization (WHO) ATC/DDD classification. A total of 190 patients were admitted to the Intensive Care Unit, among which 51% were male, with a mean age of 53.4 ± 17.76 years, with the most prevalent age group being between 60 and 74 years (30.5 %). Among the diagnostic hypotheses of hospitalization, 26% were coronavirus infections. Of the hospitalized patients, 35.71% used some antimicrobial treatment, with meropenem being the most consumed (DDD 225.24). The study of the use of antimicrobials is an essential tool to guide the actions of the SCIH (Hospital Infection Control Service) that minimize microbial resistance and the indiscriminate and irrational use of these drugs and for the economic aspect. Furthermore, implementing an antimicrobial stewardship program optimizes the safe use of this important class of drugs. |
id |
UNIFEI_aec1d7849cf17a47aef19dfc6d65c971 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/27592 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Study of antimicrobial consumption in Intensive Care Center of a University hospital in the North RegionEstudio de consumo de antimicrobianos en el Centro de Cuidados Intensivos de un Hospital Universitario de la Región NorteEstudo de consumo de antimicrobianos do Centro de Terapia Intensiva de um hospital Universitário da Região Norte Unidad de Cuidados IntensivosConsumo de antimicrobianosMultirresistencia microbiana.Intensive Care CenterAntimicrobial consumptionMicrobial resistance.Unidade de Terapia IntensivaConsumo de antimicrobianosMultirresistência microbiana.The indiscriminate and excessive use of antimicrobials directly contributes to the development of bacterial resistance, increasing treatment expenses, morbidity and mortality rates, hospitalization time, and various adverse reactions. Therefore, the study's objective was to evaluate and quantify the consumption of antimicrobials used in the ICU of a Federal Public Hospital. Antimicrobial consumption was expressed as a defined daily dose (DDD) per 1000 patients/day. It was used in the World Health Organization (WHO) ATC/DDD classification. A total of 190 patients were admitted to the Intensive Care Unit, among which 51% were male, with a mean age of 53.4 ± 17.76 years, with the most prevalent age group being between 60 and 74 years (30.5 %). Among the diagnostic hypotheses of hospitalization, 26% were coronavirus infections. Of the hospitalized patients, 35.71% used some antimicrobial treatment, with meropenem being the most consumed (DDD 225.24). The study of the use of antimicrobials is an essential tool to guide the actions of the SCIH (Hospital Infection Control Service) that minimize microbial resistance and the indiscriminate and irrational use of these drugs and for the economic aspect. Furthermore, implementing an antimicrobial stewardship program optimizes the safe use of this important class of drugs.El uso indiscriminado y excesivo de antimicrobianos contribuye directamente al desarrollo de resistencias bacterianas, aumentando los gastos de tratamiento, las tasas de morbilidad y mortalidad, el tiempo de hospitalización y la ocurrencia de diversas reacciones adversas. El objetivo del estudio fue evaluar y cuantificar el consumo de antimicrobianos utilizados en la UTI de un Hospital Público Federal. Estudio descriptivo, transversal y retrospectivo realizado en la Unidad de Cuidados Intensivos (UCI) de un Hospital Universitario Federal de la región Norte, de enero a diciembre de 2020. El consumo de antimicrobianos se expresó como dosis diaria definida (DDD) por 1000 pacientes/día. Se utilizó la clasificación ATC/DDD de la Organización Mundial de la Salud (OMS). Un total de 190 pacientes ingresaron en la Unidad de Cuidados Intensivos, de los cuales el 51 % eran del sexo masculino, con una edad promedio de 53,4 ± 17,76 años, siendo el grupo de edad más prevalente el de 60 a 74 años (30,5 %). ntre las hipótesis diagnósticas de hospitalización, el 26% fueron infección por coronavirus. De los pacientes hospitalizados, el 35,71% utilizaba algún tipo de tratamiento antimicrobiano, siendo el meropenem el más consumido (DDD 225,24). El estudio del uso de antimicrobianos es una herramienta importante tanto para orientar las acciones del SCIH (Servicio de Control de Infecciones Hospitalarias) que minimicen la resistencia microbiana y el uso indiscriminado e irracional de estos fármacos, como por el aspecto económico. Además, la implementación de un programa de administración de antimicrobianos optimiza el uso seguro de esta importante clase de medicamentos.O uso indiscriminado e excessivo de antimicrobianos contribui diretamente para o desenvolvimento da resistência bacteriana, elevando as despesas com tratamentos, os índices de morbimortalidade, o tempo de internação e a ocorrência de reações adversas diversas. O objetivo do estudo foi avaliar e quantificar o consumo de antimicrobianos utilizados na UTI de um Hospital Público Federal. Estudo descritivo, transversal e retrospectivo realizado na Unidade de Terapia Intensiva (UTI) de um Hospital Universitário Federal da região Norte, durante o período de janeiro a dezembro de 2020. O consumo dos antimicrobianos foi expresso em Dose Diária Definida (DDD) por 1000 pacientes/dia. Utilizou-se a classificação ATC/ DDD da Organização Mundial de Saúde (OMS). Ao total 190 pacientes estiveram internados na Unidade de Terapia Intensiva, dentre os quais 51% do sexo masculino, com média de idade de 53,4 ± 17,76 anos, sendo a faixa etária mais prevalente entre 60 e 74 anos (30,5%). Dentre as hipóteses diagnósticas de internação, 26% foi de infecção por coronavírus. Dos pacientes internados, 35,71% utilizaram algum tipo de tratamento com antimicrobiano, sendo o meropenem o mais consumido (DDD 225,24). O estudo da utilização de antimicrobianos é uma importante ferramenta tanto para nortear as ações do SCIH (Serviço de Controle de Infecção Hospitalar) que minimizem a resistência microbiana e o uso indiscriminado e irracional destes medicamentos quanto pelo aspecto econômico. Além disso, a implantação de um programa de stewardship de antimicrobianos otimiza o uso seguro dessa importante classe de fármacos.Research, Society and Development2022-03-27info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2759210.33448/rsd-v11i5.27592Research, Society and Development; Vol. 11 No. 5; e0611527592Research, Society and Development; Vol. 11 Núm. 5; e0611527592Research, Society and Development; v. 11 n. 5; e06115275922525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/27592/24257Copyright (c) 2022 Maria Gorete Lima Marinho; Suzany Helena da Silva Cândido; Mírian Brasil Magalhães de Oliveira; Rebeka Caribé Badinhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessMarinho, Maria Gorete Lima Cândido, Suzany Helena da Silva Oliveira, Mírian Brasil Magalhães de Badin, Rebeka Caribé2022-04-17T18:18:56Zoai:ojs.pkp.sfu.ca:article/27592Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:45:16.612918Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Study of antimicrobial consumption in Intensive Care Center of a University hospital in the North Region Estudio de consumo de antimicrobianos en el Centro de Cuidados Intensivos de un Hospital Universitario de la Región Norte Estudo de consumo de antimicrobianos do Centro de Terapia Intensiva de um hospital Universitário da Região Norte |
title |
Study of antimicrobial consumption in Intensive Care Center of a University hospital in the North Region |
spellingShingle |
Study of antimicrobial consumption in Intensive Care Center of a University hospital in the North Region Marinho, Maria Gorete Lima Unidad de Cuidados Intensivos Consumo de antimicrobianos Multirresistencia microbiana. Intensive Care Center Antimicrobial consumption Microbial resistance. Unidade de Terapia Intensiva Consumo de antimicrobianos Multirresistência microbiana. |
title_short |
Study of antimicrobial consumption in Intensive Care Center of a University hospital in the North Region |
title_full |
Study of antimicrobial consumption in Intensive Care Center of a University hospital in the North Region |
title_fullStr |
Study of antimicrobial consumption in Intensive Care Center of a University hospital in the North Region |
title_full_unstemmed |
Study of antimicrobial consumption in Intensive Care Center of a University hospital in the North Region |
title_sort |
Study of antimicrobial consumption in Intensive Care Center of a University hospital in the North Region |
author |
Marinho, Maria Gorete Lima |
author_facet |
Marinho, Maria Gorete Lima Cândido, Suzany Helena da Silva Oliveira, Mírian Brasil Magalhães de Badin, Rebeka Caribé |
author_role |
author |
author2 |
Cândido, Suzany Helena da Silva Oliveira, Mírian Brasil Magalhães de Badin, Rebeka Caribé |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Marinho, Maria Gorete Lima Cândido, Suzany Helena da Silva Oliveira, Mírian Brasil Magalhães de Badin, Rebeka Caribé |
dc.subject.por.fl_str_mv |
Unidad de Cuidados Intensivos Consumo de antimicrobianos Multirresistencia microbiana. Intensive Care Center Antimicrobial consumption Microbial resistance. Unidade de Terapia Intensiva Consumo de antimicrobianos Multirresistência microbiana. |
topic |
Unidad de Cuidados Intensivos Consumo de antimicrobianos Multirresistencia microbiana. Intensive Care Center Antimicrobial consumption Microbial resistance. Unidade de Terapia Intensiva Consumo de antimicrobianos Multirresistência microbiana. |
description |
The indiscriminate and excessive use of antimicrobials directly contributes to the development of bacterial resistance, increasing treatment expenses, morbidity and mortality rates, hospitalization time, and various adverse reactions. Therefore, the study's objective was to evaluate and quantify the consumption of antimicrobials used in the ICU of a Federal Public Hospital. Antimicrobial consumption was expressed as a defined daily dose (DDD) per 1000 patients/day. It was used in the World Health Organization (WHO) ATC/DDD classification. A total of 190 patients were admitted to the Intensive Care Unit, among which 51% were male, with a mean age of 53.4 ± 17.76 years, with the most prevalent age group being between 60 and 74 years (30.5 %). Among the diagnostic hypotheses of hospitalization, 26% were coronavirus infections. Of the hospitalized patients, 35.71% used some antimicrobial treatment, with meropenem being the most consumed (DDD 225.24). The study of the use of antimicrobials is an essential tool to guide the actions of the SCIH (Hospital Infection Control Service) that minimize microbial resistance and the indiscriminate and irrational use of these drugs and for the economic aspect. Furthermore, implementing an antimicrobial stewardship program optimizes the safe use of this important class of drugs. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-03-27 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/27592 10.33448/rsd-v11i5.27592 |
url |
https://rsdjournal.org/index.php/rsd/article/view/27592 |
identifier_str_mv |
10.33448/rsd-v11i5.27592 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/27592/24257 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 11 No. 5; e0611527592 Research, Society and Development; Vol. 11 Núm. 5; e0611527592 Research, Society and Development; v. 11 n. 5; e0611527592 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052707804020736 |